Project Aim(s): The development of neurotrophic factor therapy for Parkinson's disease (PD).
Website
Disease area
Field of research
Principal Investigator/ Researcher Names
Dr. Gerard O' Keeffe
Institution
Start date
Project completed
Yes
End/expected end date
Funding body
Science Foundation Ireland (SFI)
Grant Awarded (€)
639,453
Are you looking to Recruit Research Participants?
No
Clinical trials using AAV vectors have been deemed safe and feasible in patients with Parkinson's disease (PD). We are using these vectors to deliever novel neurotrophic factors as new disease modifying therapies for Parkinson's Disease sufferers.